{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:11:03Z","timestamp":1648779063483},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,7,14]],"date-time":"2013-07-14T00:00:00Z","timestamp":1373760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00467-013-2559-8","type":"journal-article","created":{"date-parts":[[2013,7,13]],"date-time":"2013-07-13T20:19:38Z","timestamp":1373746778000},"page":"1883-1894","source":"Crossref","is-referenced-by-count":3,"title":["Making sense of the spectrum of glomerular disease associated with complement dysregulation"],"prefix":"10.1007","volume":"29","author":[{"given":"Sally Ann","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin K. S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Mark","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,14]]},"reference":[{"key":"2559_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000320901","volume":"118","author":"D Kavanagh","year":"2011","unstructured":"Kavanagh D, Goodship T (2011) Haemolytic uraemic syndrome. Nephron Clin Pract 118:37\u201342","journal-title":"Nephron Clin Pract"},{"key":"2559_CR2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","volume":"6","author":"C Loirat","year":"2011","unstructured":"Loirat C, Fremeaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6:60","journal-title":"Orphanet J Rare Dis"},{"key":"2559_CR3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","volume":"82","author":"A Servais","year":"2012","unstructured":"Servais A, Noel LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grunfeld JP, Niaudet P, Lesavre P, Fremeaux-Bacchi V (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82:454\u2013464","journal-title":"Kidney Int"},{"key":"2559_CR4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2012.212","volume":"82","author":"S Sethi","year":"2012","unstructured":"Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ (2012) C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int 82:465\u2013473","journal-title":"Kidney Int"},{"key":"2559_CR5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058\u20131066","journal-title":"N Engl J Med"},{"key":"2559_CR6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ (2001) Complement. Second of two parts. N Engl J Med 344:1140\u20131144","journal-title":"N Engl J Med"},{"key":"2559_CR7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11:785\u2013797","journal-title":"Nat Immunol"},{"key":"2559_CR8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2249.2007.03553.x","volume":"151","author":"CQ Schmidt","year":"2008","unstructured":"Schmidt CQ, Herbert AP, Hocking HG, Uhrin D, Barlow PN (2008) Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin Exp Immunol 151:14\u201324","journal-title":"Clin Exp Immunol"},{"key":"2559_CR9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nature10449","volume":"478","author":"D Weismann","year":"2011","unstructured":"Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, Charbel Issa P, Cano M, Brandstatter H, Tsimikas S, Skerka C, Superti-Furga G, Handa JT, Zipfel PF, Witztum JL, Binder CJ (2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478:76\u201381","journal-title":"Nature"},{"key":"2559_CR10","doi-asserted-by":"crossref","first-page":"19737","DOI":"10.1073\/pnas.0609791104","volume":"103","author":"N Nishida","year":"2006","unstructured":"Nishida N, Walz T, Springer TA (2006) Structural transitions of complement component C3 and its activation products. Proc Natl Acad Sci USA 103:19737\u201319742","journal-title":"Proc Natl Acad Sci USA"},{"key":"2559_CR11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","volume":"70","author":"N Besbas","year":"2006","unstructured":"Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB (2006) A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 70:423\u2013431","journal-title":"Kidney Int"},{"key":"2559_CR12","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C (2007) Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 18:2392\u20132400","journal-title":"J Am Soc Nephrol"},{"key":"2559_CR13","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844\u20131859","journal-title":"Clin J Am Soc Nephrol"},{"key":"2559_CR14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00467-003-1385-9","volume":"19","author":"CM Taylor","year":"2004","unstructured":"Taylor CM, Chua C, Howie AJ, Risdon RA (2004) Clinico-pathological findings in diarrhoea-negative haemolytic uraemic syndrome. Pediatr Nephrol 19:419\u2013425","journal-title":"Pediatr Nephrol"},{"key":"2559_CR15","first-page":"380","volume":"5","author":"M Mehrazma","year":"2011","unstructured":"Mehrazma M, Hooman N, Otukesh H (2011) Prognostic value of renal pathological findings in children with atypical hemolytic uremic syndrome Iran. J Kidney Dis 5:380\u2013385","journal-title":"J Kidney Dis"},{"key":"2559_CR16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMra1108178","volume":"366","author":"S Sethi","year":"2012","unstructured":"Sethi S, Fervenza FC (2012) Membranoproliferative glomerulonephritis\u2013a new look at an old entity. N Engl J Med 366:1119\u20131131","journal-title":"N Engl J Med"},{"key":"2559_CR17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jmg.2006.045328","volume":"44","author":"A Servais","year":"2007","unstructured":"Servais A, Fremeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grunfeld JP, Lesavre P, Noel LH, Fakhouri F (2007) Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44:193\u2013199","journal-title":"J Med Genet"},{"key":"2559_CR18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","volume":"376","author":"DP Gale","year":"2010","unstructured":"Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Fremeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC (2010) Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376:794\u2013801","journal-title":"Lancet"},{"key":"2559_CR19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","volume":"6","author":"F Fakhouri","year":"2010","unstructured":"Fakhouri F, Fremeaux-Bacchi V, Noel LH, Cook HT, Pickering MC (2010) C3 glomerulopathy: a new classification. Nat Rev Nephrol 6:494\u2013499","journal-title":"Nat Rev Nephrol"},{"key":"2559_CR20","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1093\/ndt\/gfh484","volume":"19","author":"JC Cansick","year":"2004","unstructured":"Cansick JC, Lennon R, Cummins CL, Howie AJ, McGraw ME, Saleem MA, Tizard EJ, Hulton SA, Milford DV, Taylor CM (2004) Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis. Nephrol Dial Transplant 19:2769\u20132777","journal-title":"Nephrol Dial Transplant"},{"key":"2559_CR21","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00467-009-1322-7","volume":"25","author":"B Alchi","year":"2010","unstructured":"Alchi B, Jayne D (2010) Membranoproliferative glomerulonephritis. Pediatr Nephrol 25:1409\u20131418","journal-title":"Pediatr Nephrol"},{"key":"2559_CR22","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","volume":"53","author":"P Warwicker","year":"1998","unstructured":"Warwicker P, Goodship TH, Donne RL, Pirson Y, Nicholls A, Ward RM, Turnpenny P, Goodship JA (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53:836\u2013844","journal-title":"Kidney Int"},{"key":"2559_CR23","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G (2009) Atypical hemolytic\u2013uremic syndrome. N Engl J Med 361:1676\u20131687","journal-title":"N Engl J Med"},{"key":"2559_CR24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","volume":"365","author":"LT Roumenina","year":"2011","unstructured":"Roumenina LT, Loirat C, Dragon-Durey MA, Halbwachs-Mecarelli L, Sautes-Fridman C, Fremeaux-Bacchi V (2011) Alternative complement pathway assessment in patients with atypical HUS. J Immunol Methods 365:8\u201326","journal-title":"J Immunol Methods"},{"key":"2559_CR25","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","volume":"100","author":"A Richards","year":"2003","unstructured":"Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Muslumanoglu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship TH (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci USA 100:12966\u201312971","journal-title":"Proc Natl Acad Sci USA"},{"key":"2559_CR26","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","volume":"41","author":"V Fremeaux-Bacchi","year":"2004","unstructured":"Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, Vigneau C, Kuypers D, Boudailliez B, Loirat C, Rondeau E, Fridman WH (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 41:e84","journal-title":"J Med Genet"},{"key":"2559_CR27","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","volume":"112","author":"V Fr\u00e9meaux-Bacchi","year":"2008","unstructured":"Fr\u00e9meaux-Bacchi V, Miller EC, Liszewski MK, Strain L, Blouin J, Brown AL, Moghal N, Kaplan BS, Weiss RA, Lhotta K, Kapur G, Mattoo T, Nivet H, Wong W, Gie S, de Ligny BH, Fischbach M, Gupta R, Hauhart R, Meunier V, Loirat C, Dragon-Durey MA, Fridman WH, Janssen BJ, Goodship TH, Atkinson JP (2008) Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112:4948\u20134952","journal-title":"Blood"},{"key":"2559_CR28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","volume":"104","author":"E Goicoechea de Jorge","year":"2007","unstructured":"Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, Carreras L, Arranz EA, Garrido CA, Lopez-Trascasa M, Sanchez-Corral P, Morgan BP, Rodriguez de Cordoba S (2007) Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci USA 104:240\u2013245","journal-title":"Proc Natl Acad Sci USA"},{"key":"2559_CR29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM (2009) Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 361:345\u2013357","journal-title":"N Engl J Med"},{"key":"2559_CR30","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.4049\/jimmunol.0804031","volume":"182","author":"VP Ferreira","year":"2009","unstructured":"Ferreira VP, Herbert AP, Cortes C, McKee KA, Blaum BS, Esswein ST, Uhrin D, Barlow PN, Pangburn MK, Kavanagh D (2009) The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome. J Immunol 182:7009\u20137018","journal-title":"J Immunol"},{"key":"2559_CR31","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jmg.2005.030783","volume":"42","author":"V Fremeaux-Bacchi","year":"2005","unstructured":"Fremeaux-Bacchi V, Kemp EJ, Goodship JA, Dragon-Durey MA, Strain L, Loirat C, Deng HW, Goodship TH (2005) The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J Med Genet 42:852\u2013856","journal-title":"J Med Genet"},{"key":"2559_CR32","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","volume":"120","author":"R Martinez-Barricarte","year":"2010","unstructured":"Martinez-Barricarte R, Heurich M, Valdes-Canedo F, Vazquez-Martul E, Torreira E, Montes T, Tortajada A, Pinto S, Lopez-Trascasa M, Morgan BP, Llorca O, Harris CL, Rodriguez de Cordoba S (2010) Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J Clin Invest 120:3702\u20133712","journal-title":"J Clin Invest"},{"key":"2559_CR33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jmg.2005.038315","volume":"43","author":"MA Abrera-Abeleda","year":"2006","unstructured":"Abrera-Abeleda MA, Nishimura C, Smith JL, Sethi S, McRae JL, Murphy BF, Silvestri G, Skerka C, Jozsi M, Zipfel PF, Hageman GS, Smith RJ (2006) Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet 43:582\u2013589","journal-title":"J Med Genet"},{"key":"2559_CR34","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1681\/ASN.2010080795","volume":"22","author":"MA Abrera-Abeleda","year":"2011","unstructured":"Abrera-Abeleda MA, Nishimura C, Frees K, Jones M, Maga T, Katz LM, Zhang Y, Smith RJ (2011) Allelic variants of complement genes associated with dense deposit disease. J Am Soc Nephrol 22:1551\u20131559","journal-title":"J Am Soc Nephrol"},{"key":"2559_CR35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ki.5000269","volume":"70","author":"C Licht","year":"2006","unstructured":"Licht C, Heinen S, Jozsi M, Loschmann I, Saunders RE, Perkins SJ, Waldherr R, Skerka C, Kirschfink M, Hoppe B, Zipfel PF (2006) Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int 70:42\u201350","journal-title":"Kidney Int"},{"key":"2559_CR36","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ki.2008.354","volume":"75","author":"S Habbig","year":"2009","unstructured":"Habbig S, Mihatsch MJ, Heinen S, Beck B, Emmel M, Skerka C, Kirschfink M, Hoppe B, Zipfel PF, Licht C (2009) C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int 75:1230\u20131234","journal-title":"Kidney Int"},{"key":"2559_CR37","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1681\/ASN.2012020166","volume":"23","author":"TH Malik","year":"2012","unstructured":"Malik TH, Lavin PJ, Goicoechea de Jorge E, Vernon KA, Rose KL, Patel MP, de Leeuw M, Neary JJ, Conlon PJ, Winn MP, Pickering MC (2012) A hybrid CFHR3-1 gene causes familial C3 glomerulopathy. J Am Soc Nephrol 23:1155\u20131160","journal-title":"J Am Soc Nephrol"},{"key":"2559_CR38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","volume":"15","author":"MA Dragon-Durey","year":"2004","unstructured":"Dragon-Durey MA, Fremeaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschenes G, Coppo P, Herman Fridman W, Weiss L (2004) Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol 15:787\u2013795","journal-title":"J Am Soc Nephrol"},{"key":"2559_CR39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.humpath.2010.11.023","volume":"42","author":"A Servais","year":"2011","unstructured":"Servais A, Noel LH, Dragon-Durey MA, Gubler MC, Remy P, Buob D, Cordonnier C, Makdassi R, Jaber W, Boulanger E, Lesavre P, Fremeaux-Bacchi V (2011) Heterogeneous pattern of renal disease associated with homozygous Factor H deficiency. Hum Pathol 42:1305\u20131311","journal-title":"Hum Pathol"},{"key":"2559_CR40","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.molimm.2006.10.005","volume":"44","author":"SC Nilsson","year":"2007","unstructured":"Nilsson SC, Karpman D, Vaziri-Sani F, Kristoffersson AC, Salomon R, Provot F, Fremeaux-Bacchi V, Trouw LA, Blom AM (2007) A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol Immunol 44:1835\u20131844","journal-title":"Mol Immunol"},{"key":"2559_CR41","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","volume":"8","author":"JE Salmon","year":"2011","unstructured":"Salmon JE, Heuser C, Triebwasser M, Liszewski MK, Kavanagh D, Roumenina L, Branch DW, Goodship T, Fremeaux-Bacchi V, Atkinson JP (2011) Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med 8:e1001013","journal-title":"PLoS Med"},{"key":"2559_CR42","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","volume":"111","author":"CJ Fang","year":"2008","unstructured":"Fang CJ, Fremeaux-Bacchi V, Liszewski MK, Pianetti G, Noris M, Goodship TH, Atkinson JP (2008) Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 111:624\u2013632","journal-title":"Blood"},{"key":"2559_CR43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.164.3878.436","volume":"164","author":"RE Spitzer","year":"1969","unstructured":"Spitzer RE, Vallota EH, Forristal J, Sudora E, Stitzel A, Davis NC, West CD (1969) Serum C\u20193 lytic system in patients with glomerulonephritis. Science 164:436\u2013437","journal-title":"Science"},{"key":"2559_CR44","first-page":"253","volume":"54","author":"AT Gewurz","year":"1983","unstructured":"Gewurz AT, Imherr SM, Strauss S, Gewurz H, Mold C (1983) C3 nephritic factor and hypocomplementaemia in a clinically healthy individual. Clin Exp Immunol 54:253\u2013258","journal-title":"Clin Exp Immunol"},{"key":"2559_CR45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM197602262940902","volume":"294","author":"JG Sissons","year":"1976","unstructured":"Sissons JG, West RJ, Fallows J, Williams DG, Boucher BJ, Amos N, Peters DK (1976) The complement abnormalities of lipodystrophy. N Engl J Med 294:461\u2013465","journal-title":"N Engl J Med"},{"key":"2559_CR46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.07900811","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Meyer NC, Wang K, Nishimura C, Frees K, Jones M, Katz LM, Sethi S, Smith RJ (2012) Causes of alternative pathway dysregulation in dense deposit disease. Clin J Am Soc Nephrol 7:265\u2013274","journal-title":"Clin J Am Soc Nephrol"},{"key":"2559_CR47","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ki.2012.250","volume":"82","author":"D Paixao-Cavalcante","year":"2012","unstructured":"Paixao-Cavalcante D, Lopez-Trascasa M, Skattum L, Giclas PC, Goodship TH, de Cordoba SR, Truedsson L, Morgan BP, Harris CL (2012) Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int 82:1084\u20131092","journal-title":"Kidney Int"},{"key":"2559_CR48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","volume":"16","author":"MA Dragon-Durey","year":"2005","unstructured":"Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Fremeaux-Bacchi V (2005) Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16:555\u2013563","journal-title":"J Am Soc Nephrol"},{"key":"2559_CR49","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","volume":"110","author":"M Jozsi","year":"2007","unstructured":"Jozsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, Oppermann M, Skerka C, Zipfel PF (2007) Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood 110:1516\u20131518","journal-title":"Blood"},{"key":"2559_CR50","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.1200679","volume":"189","author":"C Blanc","year":"2012","unstructured":"Blanc C, Roumenina LT, Ashraf Y, Hyvarinen S, Sethi SK, Ranchin B, Niaudet P, Loirat C, Gulati A, Bagga A, Fridman WH, Sautes-Fridman C, Jokiranta TS, Fremeaux-Bacchi V, Dragon-Durey MA (2012) Overall neutralization of complement factor h by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome. J Immunol 189:3528\u20133537","journal-title":"J Immunol"},{"key":"2559_CR51","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","volume":"111","author":"M Jozsi","year":"2008","unstructured":"Jozsi M, Licht C, Strobel S, Zipfel SL, Richter H, Heinen S, Zipfel PF, Skerka C (2008) Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency. Blood 111:1512\u20131514","journal-title":"Blood"},{"key":"2559_CR52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2012.05.009","volume":"52","author":"TH Goodship","year":"2012","unstructured":"Goodship TH, Pappworth IY, Toth T, Denton M, Houlberg K, McCormick F, Warland D, Moore I, Hunze EM, Staniforth SJ, Hayes C, Cavalcante DP, Kavanagh D, Strain L, Herbert AP, Schmidt CQ, Barlow PN, Harris CL, Marchbank KJ (2012) Factor H autoantibodies in membranoproliferative glomerulonephritis. Mol Immunol 52:200\u2013206","journal-title":"Mol Immunol"},{"key":"2559_CR53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2215\/CJN.05750611","volume":"7","author":"D Kavanagh","year":"2012","unstructured":"Kavanagh D, Pappworth IY, Anderson H, Hayes CM, Moore I, Hunze EM, Bennaceur K, Roversi P, Lea S, Strain L, Ward R, Plant N, Nailescu C, Goodship TH, Marchbank KJ (2012) Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon? Clin J Am Soc Nephrol 7:417\u2013426","journal-title":"Clin J Am Soc Nephrol"},{"key":"2559_CR54","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.molimm.2010.02.002","volume":"47","author":"S Strobel","year":"2010","unstructured":"Strobel S, Zimmering M, Papp K, Prechl J, Jozsi M (2010) Anti-factor B autoantibody in dense deposit disease. Mol Immunol 47:1476\u20131483","journal-title":"Mol Immunol"},{"key":"2559_CR55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","volume":"45","author":"M Lemaire","year":"2013","unstructured":"Lemaire M, Fremeaux-Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, Fakhouri F, Taque S, Nobili F, Martinez F, Ji W, Overton JD, Mane SM, Nurnberg G, Altmuller J, Thiele H, Morin D, Deschenes G, Baudouin V, Llanas B, Collard L, Majid MA, Simkova E, Nurnberg P, Rioux-Leclerc N, Moeckel GW, Gubler MC, Hwa J, Loirat C, Lifton RP (2013) Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet 45:531\u2013536","journal-title":"Nat Genet"},{"key":"2559_CR56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1681\/ASN.2012090903","volume":"24","author":"F Ozaltin","year":"2013","unstructured":"Ozaltin F, Li B, Rauhauser A, An SW, Soylemezoglu O, Gonul II, Taskiran EZ, Ibsirlioglu T, Korkmaz E, Bilginer Y, Duzova A, Ozen S, Topaloglu R, Besbas N, Ashraf S, Du Y, Liang C, Chen P, Lu D, Vadnagara K, Arbuckle S, Lewis D, Wakeland B, Quigg RJ, Ransom RF, Wakeland EK, Topham MK, Bazan NG, Mohan C, Hildebrandt F, Bakkaloglu A, Huang CL, Attanasio M (2013) DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN. J Am Soc Nephrol 24:377\u2013384","journal-title":"J Am Soc Nephrol"},{"key":"2559_CR57","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI117751","volume":"95","author":"K Hogasen","year":"1995","unstructured":"Hogasen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M (1995) Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest 95:1054\u20131061","journal-title":"J Clin Invest"},{"key":"2559_CR58","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0002-9440(10)64481-1","volume":"161","author":"GA Hegasy","year":"2002","unstructured":"Hegasy GA, Manuelian T, Hogasen K, Jansen JH, Zipfel PF (2002) The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion. Am J Pathol 161:2027\u20132034","journal-title":"Am J Pathol"},{"key":"2559_CR59","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","volume":"31","author":"MC Pickering","year":"2002","unstructured":"Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31:424\u2013428","journal-title":"Nat Genet"},{"key":"2559_CR60","first-page":"608","volume":"118","author":"KL Rose","year":"2008","unstructured":"Rose KL, Paixao-Cavalcante D, Fish J, Manderson AP, Malik TH, Bygrave AE, Lin T, Sacks SH, Walport MJ, Cook HT, Botto M, Pickering MC (2008) Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J Clin Invest 118:608\u2013618","journal-title":"J Clin Invest"},{"key":"2559_CR61","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20070301","volume":"204","author":"MC Pickering","year":"2007","unstructured":"Pickering MC, de Jorge EG, Martinez-Barricarte R, Recalde S, Garcia-Layana A, Rose KL, Moss J, Walport MJ, Cook HT, de C\u00f3rdoba SR, Botto M (2007) Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med 204:1249\u20131256","journal-title":"J Exp Med"},{"key":"2559_CR62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1681\/ASN.2012060570","volume":"24","author":"AM Lesher","year":"2013","unstructured":"Lesher AM, Zhou L, Kimura Y, Sato S, Gullipalli D, Herbert AP, Barlow PN, Eberhardt HU, Skerka C, Zipfel PF, Hamano T, Miwa T, Tung KS, Song WC (2013) Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. J Am Soc Nephrol 24:53\u201365","journal-title":"J Am Soc Nephrol"},{"key":"2559_CR63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1681\/ASN.2012060571","volume":"24","author":"MM Ruseva","year":"2013","unstructured":"Ruseva MM, Vernon KA, Lesher AM, Schwaeble WJ, Ali YM, Botto M, Cook T, Song W, Stover CM, Pickering MC (2013) Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency. J Am Soc Nephrol 24:43\u201352","journal-title":"J Am Soc Nephrol"},{"key":"2559_CR64","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0272-6386(89)80133-7","volume":"13","author":"RL Siegler","year":"1989","unstructured":"Siegler RL, Brewer ED, Pysher TJ (1989) Hemolytic uremic syndrome associated with glomerular disease. Am J Kidney Dis 13:144\u2013147","journal-title":"Am J Kidney Dis"},{"key":"2559_CR65","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1093\/oxfordjournals.ndt.a027219","volume":"11","author":"TK Mattoo","year":"1996","unstructured":"Mattoo TK, al Mohrij O, Kagalwalla Y, Said R, Kagalwalla A, Abu-Talib AR (1996) Membranoproliferative glomerulonephritis and haemolytic\u2013uraemic syndrome in a patient with congenital chloride diarrhoea. Nephrol Dial Transplant 11:2482\u20132484","journal-title":"Nephrol Dial Transplant"},{"key":"2559_CR66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ndt\/gfg470","volume":"19","author":"M Cooper","year":"2004","unstructured":"Cooper M, McGraw ME, Unsworth DJ, Mathieson P (2004) Familial mesangio-capillary glomerulonephritis with initial presentation as haemolytic uraemic syndrome. Nephrol Dial Transplant 19:230\u2013233","journal-title":"Nephrol Dial Transplant"},{"key":"2559_CR67","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1093\/ndt\/gfr436","volume":"26","author":"N Lorcy","year":"2011","unstructured":"Lorcy N, Rioux-Leclercq N, Lombard ML, Le Pogamp P, Vigneau C (2011) Three kidneys, two diseases, one antibody? Nephrol Dial Transplant 26:3811\u20133813","journal-title":"Nephrol Dial Transplant"},{"key":"2559_CR68","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.ki.5000155","volume":"69","author":"F Vaziri-Sani","year":"2006","unstructured":"Vaziri-Sani F, Holmberg L, Sj\u00f6holm AG, Kristoffersson AC, Manea M, Fr\u00e9meaux-Bacchi V, Fehrman-Ekholm I, Raafat R, Karpman D (2006) Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int 69:981\u2013988","journal-title":"Kidney Int"},{"key":"2559_CR69","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/ndt\/gfr422","volume":"26","author":"D Brackman","year":"2011","unstructured":"Brackman D, Sartz L, Leh S, Kristoffersson AC, Bjerre A, Tati R, Fr\u00e9meaux-Bacchi V, Karpman D (2011) Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis. Nephrol Dial Transplant 26:3399\u20133403","journal-title":"Nephrol Dial Transplant"},{"key":"2559_CR70","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2249.2007.03574.x","volume":"151","author":"MC Pickering","year":"2008","unstructured":"Pickering MC, Cook HT (2008) Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin Exp Immunol 151:210\u2013230","journal-title":"Clin Exp Immunol"},{"key":"2559_CR71","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00467-012-2183-z","volume":"27","author":"E Volokhina","year":"2012","unstructured":"Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L (2012) Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding. Pediatr Nephrol 27:1519\u20131524","journal-title":"Pediatr Nephrol"},{"key":"2559_CR72","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1681\/ASN.2010060647","volume":"22","author":"L Bao","year":"2011","unstructured":"Bao L, Haas M, Quigg RJ (2011) Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol 22:285\u2013295","journal-title":"J Am Soc Nephrol"},{"key":"2559_CR73","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, N\u00fcrnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C (2013) Terminal complement inhibitor eculizumab in atypical hemolytic\u2013uremic syndrome. N Engl J Med 368:2169\u20132181","journal-title":"N Engl J Med"},{"key":"2559_CR74","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2215\/CJN.12901211","volume":"7","author":"AS Bomback","year":"2012","unstructured":"Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D\u2019Agati VD, Canetta PA, Radhakrishnan J, Appel GB (2012) Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol 7:748\u2013756","journal-title":"Clin J Am Soc Nephrol"},{"key":"2559_CR75","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMc1111953","volume":"366","author":"M Vivarelli","year":"2012","unstructured":"Vivarelli M, Pasini A, Emma F (2012) Eculizumab for the treatment of dense-deposit disease. N Engl J Med 366:1163\u20131165","journal-title":"N Engl J Med"},{"key":"2559_CR76","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJMc1106619","volume":"366","author":"S Radhakrishnan","year":"2012","unstructured":"Radhakrishnan S, Lunn A, Kirschfink M, Thorner P, Hebert D, Langlois V, Pluthero F, Licht C (2012) Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med 366:1165\u20131166","journal-title":"N Engl J Med"},{"key":"2559_CR77","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","volume":"8","author":"J Zuber","year":"2012","unstructured":"Zuber J, Fakhouri F, Roumenina LT, Loirat C, Fremeaux-Bacchi V, French Study Group for aHUS\/C3G (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8:643\u2013657","journal-title":"Nat Rev Nephrol"},{"key":"2559_CR78","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/ki.2008.657","volume":"75","author":"S Sethi","year":"2009","unstructured":"Sethi S, Gamez JD, Vrana JA, Theis JD, Bergen HR 3rd, Zipfel PF, Dogan A, Smith RJ (2009) Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway. Kidney Int 75:952\u2013960","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2559-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-013-2559-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-013-2559-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T04:33:25Z","timestamp":1563424405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-013-2559-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,14]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["2559"],"URL":"https:\/\/doi.org\/10.1007\/s00467-013-2559-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,14]]}}}